BPH Global Registry

Launched by SOCIÉTÉ INTERNATIONALE D'UROLOGIE · Sep 15, 2022

Keywords

ClinConnect Summary

The BPH Global Registry is a clinical trial designed to gather important information about men who are receiving surgical treatments for benign prostatic hyperplasia (BPH), a condition that causes urinary problems due to an enlarged prostate. This trial aims to collect data on patients' experiences and outcomes, helping to improve future treatments. If you are a man between the ages of 65 and 74 and have been diagnosed with BPH along with lower urinary tract symptoms, you may be eligible to participate.

Participants in this trial will be asked to provide information about their health and treatment outcomes. It is important to note that this study is specifically looking for men who are experiencing symptoms and have received some form of medical or surgical treatment for BPH. If you are not experiencing symptoms or have not been treated for BPH, you would not qualify for this study. By joining, you will be contributing to a better understanding of how these treatments work, which could benefit others in the future.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Primary diagnosis of BPH with LUTS with prescribed medical treatment or surgical intervention
• Exclusion Criteria:
• • Non-symptomatic BPH
• • No treatment prescribed for BPH